$0.03

0.002 (8%)

General Information

Bioxyne Limited
BXN
http://www.bioxyne.com
Biotechnology
5
202

Current Price Data+

Current Price $0.027
Open $0.027
High $0.027
Low $0.027
Last Close $0.025
Volume 439352
Price Movement $0.00 ( 8% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Stock Price

Company Overview

Business Description

Bioxyne Limited (BXN) is a biopharmaceutical company focused on manufacture, marketing and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum. In past years, the principal activities of the Group were the research and development of products for the ongoing treatment of Chronic Obstructive Pulmonary Disease.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2015 A 0.2 0.1 -28.6% 15.5 0.0 0.0% 0.0%
2014 A 0.3 0.1 0.0% 7.1 0.0 0.0% 0.0%
2013 A -6.2 -4.0 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2013 A 2014 F 2015 F 2013 A 2014 F 2015 F 2013 A 2014 F 2015 F
Bioxyne (BXN) $5M -0.2857 0.0000 0.0000 25.0000 0.0000 0.0000 0.00% 0.00% 0.00%
CSL (CSL) $52,988M 0.3109 0.0454 0.2583 30.9274 29.5829 23.5096 1.39% 1.45% 2.20%
Mesoblast (MSB) $706M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $434M 1.8016 0.1736 0.0347 17.8952 15.2479 14.7364 3.77% 4.59% 4.75%
Sirtex Medical (SRX) $1,792M 0.6876 0.4570 0.4484 44.8780 30.8026 21.2659 0.64% 0.95% 1.38%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.69 27.00 4.22 0.00
Market 1.17 15.80 1.19 0.72
Sector 0.49 15.20 3.37 0.70

Directors

Name Position Start Date
Dr Peter W French Executive Director 15 Feb 2016
Mr George Xavier Cameron-Dow Non-Executive Director 21 Jul 2014
Mr Patrick Douglas Ford Non-Executive Director 20 May 2005
Mr Anthony (Tony) Peng Ho Non-Executive Director, Non-Executive Chairman 30 Oct 2012

Management

Name Position
Jarrod Travers White Chief Financial Officer,Company Secretary

Calendar of Events

Date Event
24 February 2017 Report (Interim)
28 September 2016 Report (Annual)
29 August 2016 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.